Mar 13, 2018 11:30 am UTC| Business
Leadership team to leverage best-in-class operational excellence, disciplined project execution and track record of strong cost management to unlock near- and long-term value ...
Epizyme Reports Fourth Quarter and Full Year 2017 Operating Results and 2018 Milestones
Mar 13, 2018 11:30 am UTC| Business
First Tazemetostat NDA Submission for Epithelioid Sarcoma Targeted for Fourth Quarter of 2018; Second Tazemetostat NDA Submission for Follicular Lymphoma Targeted for 2019 Multiple Phase 2 Study Data Readouts Planned in...
Mar 13, 2018 11:30 am UTC| Business
NEW YORK, March 13, 2018 -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced that the...
OpGen Announces Collaborator in Verification Study for Acuitas® Test
Mar 13, 2018 11:30 am UTC| Business
GAITHERSBURG, Md., March 13, 2018 -- OpGen, Inc. (NASDAQ:OPGN) announced today that it is collaborating with Beth Israel Deaconess Medical Center (BIDMC) in Boston on a verification study for OpGen’s Acuitas® AMR Gene...
Precision Drilling Corporation Announces Filing of Annual Disclosure Documents
Mar 13, 2018 11:05 am UTC| Business
CALGARY, Alberta, March 13, 2018 -- Precision Drilling Corporation (“Precision”) announced that it has filed its annual disclosure documents with the securities commissions in each of the provinces of Canada and the...
Mar 13, 2018 11:01 am UTC| Business
Repeat Doses of Company’s Pegzilarginase Produces Marked and Sustained Reductions in Plasma Arginine Levels Accompanying Reductions in Other Related Guanidino Compounds Also Seen Additional Arginase 1 Deficiency...
Mar 13, 2018 11:01 am UTC| Business
OXFORD, United Kingdom and CAMBRIDGE, Mass., March 13, 2018 -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM) announces the discovery of a series of antibiotic compounds that kill gonorrhoea bacteria via new...